Integer Holdings Corp (ITGR)vsNovartis AG ADR (NVS)
ITGR
Integer Holdings Corp
$88.12
+0.23%
HEALTHCARE · Cap: $2.99B
NVS
Novartis AG ADR
$146.03
+0.44%
HEALTHCARE · Cap: $277.42B
Smart Verdict
WallStSmart Research — data-driven comparison
Novartis AG ADR generates 2949% more annual revenue ($56.58B vs $1.86B). NVS leads profitability with a 23.9% profit margin vs 7.6%. ITGR appears more attractively valued with a PEG of 1.37. ITGR earns a higher WallStSmart Score of 62/100 (C+).
ITGR
Buy62
out of 100
Grade: C+
NVS
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+33.0%
Fair Value
$130.14
Current Price
$88.12
$42.02 discount
Margin of Safety
-51.8%
Fair Value
$110.12
Current Price
$146.03
$35.91 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 52.9% YoY
Reasonable price relative to book value
Mega-cap, among the largest globally
Every $100 of equity generates 35 in profit
Strong operational efficiency at 30.5%
Keeps 24 of every $100 in revenue as profit
Generating 2.9B in free cash flow
Areas to Watch
0.5% revenue growth
Grey zone — moderate risk
7.6% margin — thin
Weak financial health signals
Grey zone — moderate risk
Expensive relative to growth rate
Revenue declined 0.7%
Earnings declined 9.3%
Comparative Analysis Report
WallStSmart ResearchBull Case : ITGR
The strongest argument for ITGR centers on EPS Growth, Price/Book. PEG of 1.37 suggests the stock is reasonably priced for its growth.
Bull Case : NVS
The strongest argument for NVS centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 23.9% and operating margin at 30.5%.
Bear Case : ITGR
The primary concerns for ITGR are Revenue Growth, Altman Z-Score, Profit Margin.
Bear Case : NVS
The primary concerns for NVS are Altman Z-Score, PEG Ratio, Revenue Growth.
Key Dynamics to Monitor
ITGR profiles as a value stock while NVS is a declining play — different risk/reward profiles.
ITGR carries more volatility with a beta of 0.66 — expect wider price swings.
ITGR is growing revenue faster at 0.5% — sustainability is the question.
NVS generates stronger free cash flow (2.9B), providing more financial flexibility.
Bottom Line
ITGR scores higher overall (62/100 vs 51/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Integer Holdings Corp
HEALTHCARE · MEDICAL DEVICES · USA
Integer Holdings Corporation is an outsourced manufacturer of medical devices in the United States, Puerto Rico, Costa Rica, and internationally. The company is headquartered in Plano, Texas.
Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?